Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 2 |
2018 | 1 |
2019 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4.
Neoplasia. 2020 Jun;22(6):253-262. doi: 10.1016/j.neo.2020.04.002. Epub 2020 May 11.
Neoplasia. 2020.
PMID: 32403054
Free PMC article.
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.
Coleman DJ, Gao L, King CJ, Schwartzman J, Urrutia J, Sehrawat A, Tayou J, Balter A, Burchard J, Chiotti KE, Derrick DS, Sun D, Xia Z, Heiser LM, Alumkal JJ.
Coleman DJ, et al.
Oncogene. 2019 Jul;38(28):5658-5669. doi: 10.1038/s41388-019-0815-5. Epub 2019 Apr 17.
Oncogene. 2019.
PMID: 30996246
Free PMC article.
Item in Clipboard
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.
Coleman DJ, Gao L, Schwartzman J, Korkola JE, Sampson D, Derrick DS, Urrutia J, Balter A, Burchard J, King CJ, Chiotti KE, Heiser LM, Alumkal JJ.
Coleman DJ, et al.
Sci Rep. 2019 Mar 7;9(1):3823. doi: 10.1038/s41598-019-40518-5.
Sci Rep. 2019.
PMID: 30846826
Free PMC article.
Item in Clipboard
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.
Sehrawat A, Gao L, Wang Y, Bankhead A 3rd, McWeeney SK, King CJ, Schwartzman J, Urrutia J, Bisson WH, Coleman DJ, Joshi SK, Kim DH, Sampson DA, Weinmann S, Kallakury BVS, Berry DL, Haque R, Van Den Eeden SK, Sharma S, Bearss J, Beer TM, Thomas GV, Heiser LM, Alumkal JJ.
Sehrawat A, et al.
Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188. doi: 10.1073/pnas.1719168115. Epub 2018 Mar 26.
Proc Natl Acad Sci U S A. 2018.
PMID: 29581250
Free PMC article.
Item in Clipboard
Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer.
King CJ, Woodward J, Schwartzman J, Coleman DJ, Lisac R, Wang NJ, Van Hook K, Gao L, Urrutia J, Dane MA, Heiser LM, Alumkal JJ.
King CJ, et al.
Oncotarget. 2017 Nov 20;8(67):111084-111095. doi: 10.18632/oncotarget.22560. eCollection 2017 Dec 19.
Oncotarget. 2017.
PMID: 29340039
Free PMC article.
Item in Clipboard
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making.
Tao DL, Bailey S, Beer TM, Foss E, Beckett B, Fung A, Foster BR, Guimaraes A, Cetnar JP, Graff JN, Eilers KM, Small EJ, Corless CL, Thomas GV, Alumkal JJ.
Tao DL, et al.
JCO Precis Oncol. 2017;1:PO.16.00067. doi: 10.1200/PO.16.00067. Epub 2017 Jun 28.
JCO Precis Oncol. 2017.
PMID: 31650098
Free PMC article.
Item in Clipboard
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor.
Coleman DJ, Van Hook K, King CJ, Schwartzman J, Lisac R, Urrutia J, Sehrawat A, Woodward J, Wang NJ, Gulati R, Thomas GV, Beer TM, Gleave M, Korkola JE, Gao L, Heiser LM, Alumkal JJ.
Coleman DJ, et al.
Oncotarget. 2016 Jun 28;7(26):40690-40703. doi: 10.18632/oncotarget.9816.
Oncotarget. 2016.
PMID: 27276681
Free PMC article.
Item in Clipboard
Cite
Cite